Form 4 Tracker
LIGAND PHARMACEUTICALS INC
LGND

40 insider filings · Latest: Oct 2, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 10, 2025Jul 10 9:08 PMKOZARICH JOHN W
Proposed Sale
934$125.00$116.8K—

View →

Jun 23, 2025Jun 23 9:07 PMANDREW THOMAS REARDON
Proposed Sale
500$114.08$57.0K—

View →

Jun 10, 2025Jun 10 10:49 PMANDREW THOMAS REARDON
Proposed Sale
500$114.54$57.3K—

View →

May 15, 2025May 15 9:14 PMANDREW THOMAS REARDON
Proposed Sale
1,000$104.00$104.0K—

View →

Mar 18, 2025Mar 18 8:01 PMSabba Stephen L
Proposed Sale
2,406$106.00$255.0K—

View →

Mar 4, 2025Mar 4 10:10 PMEspinoza Octavio
Proposed Sale
5,000$115.03$575.1K—

View →

Dec 23, 2024Dec 24 1:19 AMEspinoza Octavio
Proposed Sale
2,104$116.37$244.9K—

View →

Nov 26, 2024Nov 27 9:44 PMLAMATTINA JOHN L
Proposed Sale
2,406$119.19$286.8K—

View →

Sep 23, 2024Sep 23 9:30 PMReardon Andrew
Proposed Sale
2,000$99.60$199.2K—

View →

Sep 23, 2024Sep 23 9:27 PMKorenberg Matthew E
Proposed Sale
14,437$101.50$1.5M—

View →

Sep 20, 2024Sep 20 10:12 PMKorenberg Matthew E
Proposed Sale
6,275$104.10$653.2K—

View →

Sep 20, 2024Sep 20 9:39 PMEspinoza Octavio
Proposed Sale
1,275$103.94$132.5K—

View →

Aug 28, 2024Aug 28 8:39 PMReardon Andrew
Proposed Sale
1,500$106.39$159.6K—

View →

Aug 22, 2024Aug 22 10:05 PMKorenberg Matthew E
Proposed Sale
18,858$105.03$2.0M—

View →

Nov 11, 2024—Korenberg Matthew E
Proposed Sale
32,183$120.33$3.9M—

View →

← Previous

Page 4 of 4

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Oct 2, 2026Oct 6 8:35 PMAndrew ReardonCLO & Secretary
Option Exercise
340$52.2729,104(D)

View →

Aug 12, 2026Aug 14 9:05 PMOctavio EspinozaChief Financial Officer
Option Exercise
31,641$70.040(D)

View →

Aug 12, 2026Aug 14 9:04 PMJason HaasDirector
Option Exercise
6,138$51.560(D)

View →

Aug 3, 2026Aug 4 10:42 PMAndrew ReardonCLO & Secretary
Option Exercise
5,000$52.2729,444(D)

View →

Jul 1, 2026Jul 6 9:11 PMAndrew ReardonCLO & Secretary
Option Exercise
5,000$52.2734,444(D)

View →

Jun 16, 2026Jun 18 12:37 PMStephen L SabbaDirector
Option Exercise
2,145$66.130(D)

View →

Jun 12, 2026Jun 16 1:06 AMJason HaasDirector
Option Exercise
4,000$51.566,138(D)

View →

Jun 5, 2026Jun 12 9:27 PMJason AryehDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 11:42 PMMartine ZimmermannDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 11:41 PMStephen L SabbaDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 11:41 PMJohn L LamattinaDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 11:40 PMJohn W KozarichDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 11:35 PMJason HaasDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 5, 2026Jun 9 11:35 PMNancy Ryan GrayDirector
Grant/Award
2,938$237.002,938(D)

View →

Jun 1, 2026Jun 2 10:22 PMAndrew ReardonCLO & Secretary
Option Exercise
5,000$52.2739,444(D)

View →

May 27, 2026May 28 11:43 PMOctavio EspinozaChief Financial Officer
Option Exercise
1,736$63.6217,407(D)

View →

May 13, 2026May 15 1:08 AMJohn W KozarichDirector
Option Exercise
1,575$69.510(D)

View →

May 12, 2026May 15 1:08 AMJohn W KozarichDirector
Option Exercise
459$69.511,575(D)

View →

May 1, 2026May 5 12:20 AMAndrew ReardonCLO & Secretary
Option Exercise
5,000$52.2744,444(D)

View →

Apr 1, 2026Apr 2 10:56 PMAndrew ReardonCLO & Secretary
Option Exercise
5,000$52.2749,444(D)

View →

Page 1 of 2

Next →